Results 201 to 210 of about 805,583 (361)

G-CSF-Producing Giant Squamous Cell Carcinoma (SCC): Changes in Serum G-CSF in Parallel with SCC Antigen

, 2007
Takeshi Nara, Hanako Atsuta, Naoto Koizumi, Hideya Takenaka, Norito Katoh, Saburo Kishimoto   +5 more
openalex   +2 more sources

Rate of locoregional recurrence among patients with oropharyngeal squamous cell carcinoma with known HPV status: a systematic review

, 2020
Jasmin Asheer, Jakob Schmidt Jensen, Christian Grønhøj, Kathrine Kronberg Jakobsen, Christian von Buchwald   +4 more
openalex   +1 more source

Basaloid squamous cell carcinoma

Journal of Oral and Maxillofacial Pathology, 2012
Poornima, V, Patankar, Sangeeta R, Gokul, S, Khot, Komal   +3 more
openaire   +3 more sources

Selective Targeting of Immune Checkpoints HLA‐G and CD47 Using Novel Dual Signaling Protein DSP216 Promotes Innate Anticancer Immunity

Advanced Science, EarlyView.
The inhibitory immune checkpoints HLA‐G and CD47 are expressed on certain tumor types and inhibit immune cells in the tumor microenvironment. DSP216 binds specifically to cancer cells expressing both HLA‐G and CD47, and blocks their inhibitory signaling.
Lisa J. Jacob, Liat Tamir, Mufeed Abdeen, Ami Tamir, Alexandra Aronin, Itai Bloch, Roy Kahn, Iris Pecker, Mark Tykocinski, Gerwin Huls, Yaron Pereg, Ayelet Chajut, Edwin Bremer   +12 more
wiley   +1 more source

Prognostic significance of tumor microenvironment assessed by machine learning algorithm in surgically resected non‐small cell lung cancer

Cancer Reports, EarlyView., 2023
Abstract Background A methodology to assess the immune microenvironment (IME) of non‐small cell lung cancer (NSCLC) has not been established, and the prognostic impact of IME factors is not yet clear. Aims This study aimed to assess the IME factors and evaluate their prognostic values. Methods and Results We assessed CD8+ tumor‐infiltrating lymphocyte (
Yukihiro Terada, Mitsuhiro Isaka, Akira Ono, Takuya Kawata, Masakuni Serizawa, Keita Mori, Koji Muramatsu, Kiyoshi Tone, Hirotsugu Kenmotsu, Keiichi Ohshima, Kenichi Urakami, Takeshi Nagashima, Masatoshi Kusuhara, Yasuto Akiyama, Takashi Sugino, Toshiaki Takahashi, Yasuhisa Ohde   +16 more
wiley   +1 more source

Mammary metaplastic squamous cell carcinoma: a case report. [PDF]

J Med Case Rep
Tianqing Y, Guoliang Z, Shuqi L, Muyi Z, Yuanqi Z, Weiqiang L, Rong Z, Jiansen Y.   +7 more
europepmc   +1 more source

Complete Clinical Response in Squamous Cell Carcinoma of the Rectum With Liver Metastases [PDF]

, 2011
Salahattin M. Sanal, Oya Nermin Sivrikoz, İnanç Karapolat, Sedat Karademır   +3 more
openalex   +1 more source

Biomimetic Cell Membrane‐Coated MOFs System for Targeted Cancer Therapy

Advanced Science, EarlyView.
Biomimetic MOF‐based drug delivery nanoplatforms synthesized using liposomes or cell membranes as camouflage for multiple cancer therapeutics. ABSTRACT The integration of metal‐organic frameworks (MOFs) with cell membrane coatings has emerged as a revolutionary strategy to enhance the therapeutic efficacy of cancer nanomedicine.
Qilu Wu, Jia Song Deon Chon, Yuxiao Feng, Kang Liang, Shiming Li, Can Yang Zhang, Jun Ge   +6 more
wiley   +1 more source

Is endoscopic submucosal dissection a first-line treatment for anal squamous cell carcinoma? [PDF]

Endosc Int Open
Gkegkes ID, Iavazzo C, Stamatiadis AP.
europepmc   +1 more source

Tumor‐Derived Exosomes Deliver Membrane‐Bound Fgl2 to Activate FcγRIIB‐Mediated Immunosuppression in Myeloid‐Derived Suppressor Cells

Advanced Science, EarlyView.
This study reveals that the Fgl2‐FcγRIIB signaling axis is a key mechanism by which MDSCs mediate tumor immune evasion. Tumor‐derived exosomes systemically activate MDSCs via this pathway, positioning this axis as a promising broad‐spectrum target for cancer immunotherapy.
Fenglin Lin, Dingqin Cai, Chunli Jian, Yaxian Qi, Linpeng Zheng, Qiao Yang, Longyao Zhang, Diangang Chen, Lingchen Li, Ping Cai, Lingyou Sun, Luping Zhang, Jianguo Sun   +12 more
wiley   +1 more source